Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis

Andri Lemarquis1, Tessa Campbell2, Maribel Aranda-Guillén3

  • 1Department of Pediatrics, Institute of Clinical Sciences, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Rheumatology and Inflammation Research, Institute of Medicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Abstract

No abstract available in PubMed .

Related Concept Videos